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Schistosomiasis is a water-borne parasitic disease that affects most tropical regions. It is caused 
by infection with parasitic worms of the genus Schistosoma and poses a big public health threat 
to affected communities and individuals. More than 200 million people are infected worldwide, 
and 85 percent of the burden is concentrated in sub -Saharan Africa. It is important to recognize 
the risk factors which favor development of infection and to focus on countries which are at high 
risk. 
In this thesis, sub- Saharan African (SSA) countries with high prevalence of 
schistosomiasis infection (living in endemic areas) were identified.  Risk factors were also 
identified and their association with schistosomiasis prevalence was assessed.  The results 
indicate that high literacy rates are associated with low schistosomiasis infection rates. Such 
results are of great public health significance because neglected tropical diseases like 
schistosomiasis could be prevented by increasing literacy in at- risk populations.  
 
                                                                             Kristen J. Mertz,  M.D., M.P.H. 
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1.0  INTRODUCTION 
Schistosomiasis is an infection with trematode parasites and is a prevalent tropical disease, 
ranking second to malaria and posing a great public health and social economic threat in sub- 
Saharan Africa (SSA) [Molyneux 2004; Hotez et al.2007]. More than 200 million people in 76 
countries have these parasites; 85 percent  live in sub –Saharan Africa [WHO 2008].A recent 
World Health Organization (WHO) report estimates that more than 600 million people are at risk 
for schistosomiasis [WHO 2002].  
Among those infected, 120 million are symptomatic and 20 million have severe clinical 
disease. Mortality was estimated at more than 250, 000 deaths per year, making it the most 
deadly neglected tropical disease (NTD) [Chitsulo et al.2002]. According to the Global Burden 
of Disease (GBD)1
                                               
1 The WHO global burden of disease (GBD) measures burden of disease using the disability-adjusted life 
year (DALY). This time-based measure combines years of life lost due to premature mortality and years of life lost 
due to time lived in states of less than full health. The DALY metric was developed in the original GBD 1990 study 
to assess the burden of disease consistently across diseases, risk factors and regions (WHO). 
[WHO], schistosomiasis caused the loss of 1.7 million disability-adjusted life  
years (DALYs) worldwide in 2001, of which 82%( 1.4 million DALYs) were lost in sub-
Saharan-Africa(SSA)alone. In 2002, WHO reported that schistosomiasis caused one quarter of 
the tropical disease cluster burden (WHO 2002).  
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1.1 THE BURDEN OF DISEASE 
Infection with urinary schistosomiasis in Africa results in approximately 18 million cases of 
bladder wall pathology and 20 million cases of hydronephrosis, and African intestinal 
schistosomiasis results in about 8.5 million cases of hepatomegaly [Van der Werf 2003].By 
extrapolation from these figures, the mortality attributable to urinary schistosomiasis could be as 
high as 150,000 per year , and the number  dying as a result of intestinal schistosomiasis could be 
as high as 130,000 per year[Fenwick 2003]. The poverty promotes higher worm burdens, yet 
poor health induced by schistosomiasis can lead to lower incomes.  Poverty attributable to 
schistosomiasis results from disfigurement or other sequelae of long-term illness, impaired 
childhood growth and cognitive development, and reduced productive capacity [Ross et al, 2002, 
King et al. 2005; Hotez& Ferris 2006, Hotez et al.2006].   
This disease is listed  among the 13 diseases classified by the WHO as “Neglected 
Tropical diseases” [Hotez et al.2007].They are named so because they persist in the poorest and 
marginalized people who are often subsistence farmers, essentially living on no money and stuck 
in poverty, with no education. Because they arise mainly in rural areas where families depend on 
subsistence agriculture, they impair agriculture productivity. Despite the severe pain and life-
long disabilities they cause, these diseases are given a low priority alongside high mortality 
diseases (HIV-AIDS, TB and Malaria) also known as “big three”. 
The neglected diseases often receive less attention by healthcare providers, national 
governments and international agencies than they merit. That is partly because not everyone 
infected becomes ill. However the disability caused by their morbidity remains a serious public 
health problem. Schistosomiasis infection is often asymptomatic and that is why incidence is not 
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known. Prevalence is the only available epidemiological parameter and in most areas, this 
measure is also incomplete. 
1.1.1 Causative Agents and Geographic Distribution 
There are five species that cause schistosomiasis in humans, namely S.mansoni, the most 
pathogenic located in tropical Africa, South West Asia, South America and Caribbean Islands; S. 
Haematobium found in Tropical Africa and South West Asia; S.japonicum, previously found in 
Japan and now mainly in China and Philippines; S. intercalatum (West Africa); and S.mekongi 
around the Mekong river in Asia, mostly Laos and Cambodia. 
The most common species are S.mansoni and S.japonicum found in the mesenteries 
around the intestine causing intestinal schistosomiasis characterized by granuloma formation in 
the intestine and liver.  S.haematobium primarily affects the urinary tract resulting in 
inflammation of the bladder, ureteral obstruction leading to hydronephrosis, stone formation, etc.  
The five species also differ in size and shape of their eggs and egg production (S.haematobium 
and S.mansoni produce 20 to 300 eggs and S.japonicum produce 2500 eggs per worm pair per 
day) [Jordan 1993]. 
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Figure 1: Global Distribution of Schistosomiasis  
1.1.2 The Life Cycle of Schistosomiasis  
Schistosomiasis has a complex life cycle, which takes place in humans, and in an intermediate 
host of a freshwater snail. Humans become infected when they come into contact with the 
cercaria in water, where the snail hosts are found [CDC]. Different species have very similar 
patterns of human –snail life cycle. Figure 2, the diagram from the Center for Disease Control 
and Prevention (CDC), shows the life cycle of schistosome infection. The cercariae penetrate the 
skin of the host, finding their way into the blood circulation to heart, lungs, and eventually   to 
the liver where they grow and form male- female pairs, then migrate to final destination: the 
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mesenteric veins in the wall of the intestines or bladder. The flukes copulate and lay eggs. 
Through the intestinal walls, the eggs get inside the gut and are passed out in the feces 
(S.mansoni) or through urine (S.haematobium). Once they reach water, the egg hatch into 
miracidia which will now seek the snail, thus repeating the cycle [CDC] 
Schistosomiasis disease is characterized by general malaise; abdominal pain; headache; 
enlarged liver; spleen and lymph nodes; and blood; mucus and pus in stool [Ruberanziza et al.] 
Although the disease has a low mortality rate it can be debilitating and cause a high level of 
morbidity [Kabatereine 2006]. Long-term infections can lead to severe damage to human body 
and can sometimes be deadly [Kabatereine 2004, 2006]. Host immune response to eggs of 
schistosome parasites causes development of organ fibrosis and portal hypertension [Engels et 
al.2002]. The lesions can lead to blockage of blood flow. The portal hypertension can create 
collateral circulation that directs eggs into other parts of the body such as lungs and brain. In the 
case of intestinal schistosomiasis, the worms reside in the blood vessels lining the intestine. In 
urinary schistosomiasis, they live in the blood vessels of the bladder. Only about half of the eggs 
are excreted and the rest stay in the body, damaging other vital organs. In chronic hepatic 
schistosomiasis, bleeding from gastro-esophageal varices constitute the most serious also fatal 
complication [Ross et al.2002, Koukounari et al.2007] 
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Figure 2: Life Cycle of Schistosomiasis 
 
 
 
 
1.1.3 Risk Factors 
Schistosomiasis is widespread among the poor populations in less developed countries, who live 
in conditions that favor transmission and who have no access to proper health care or effective 
prevention measures. Infection is predominant in school- age children between 10 and 15 years 
old. Difference in the peak age-related prevalence of disease is due to the gradual development 
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of immunity and changes in the extent of freshwater exposure [Barbosa 2006]. Adults who 
immigrate to endemic areas are as susceptible to infection as young children [Hotez 2008]. 
Children who practice swimming are particularly at high risk, because of their prolonged and 
complete body exposure. These endemic areas are often characterized by low socioeconomic 
conditions and poor sanitary facilities, erroneous habits of the people as regards urination and 
defecation in canal water, and exposure to this polluted water by bathing, swimming, washing 
utensils and clothes, walking bare-foot during irrigation in agriculture or fishing. Snails live 
usually in marginal water and that’s why they are present in tertiary canals in high quantities. 
1.2 DIAGNOSIS OF SCHISTOSOMIASIS 
1.2.1 Stool Examination 
The gold standard for diagnosis of schistosomiasis infection is the detection of schistosomiasis 
eggs excreted  in stools for intestinal strains (S.mansoni, S.japonicum) and in the urine for 
urinary strains ( S.haematobium ).The number of eggs excreted  determines the intensity of 
infection and these parameters can be easily measured with limited laboratory equipment  in 
resource- limited settings such as sub Saharan Africa where  the fecal thick smear or Kato-Katz 
method [Katz 1972] is commonly used, because it allows quantification of infections by egg 
counts, usually expressed as per gram of feces . The determination of average number of eggs 
per gram of feces reflects the intensity of schistosomal infection.  
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1.2.2 Ultrasonography 
Ultrasonography is used to detect schistosomal pathology both at the hospital and field level 
[Hatz C F; 2001]. It has been established as a safe, rapid non-invasive and relatively inexpensive 
technique for assessing schistosomiasis –related lesions in individual patients and in community 
surveys, according to the same author. It can also be used to validate laboratory tests, to measure 
morbidity, and provides an opportunity to visualize the evolution of pathological lesions after 
treatment. 
 Ultrasonography has been useful in revealing the fibrotic liver during chronic hepatic 
schistosomiasis [Utzinger et al.2000]. Schistosomiasis infections are considered to be the most 
frequent cause of liver fibrosis worldwide [Warren KS.1984]. Although portal hypertension 
syndrome (hepatomegaly, splenomegaly, ascites), is commonly said to be cirrhotic, 
schistosomiasis should be considered too. [Doumenge 1987]. 
1.3 PREVENTION AND CONTROL 
Different control initiatives have been applied to reduce worm infections and the disease caused 
by schistosomiasis parasitic infections. However, the effects of those initiatives are quite uneven 
because of the regional and country-specific differences in available resources and political 
commitment. With combined approaches of snail control, chemotherapy, health education and 
hygiene movement, some countries like China have made substantial progress against 
schistosomiasis. In Brazil, chemotherapy programs achieved 50 to 70 percent decrease in 
prevalence. However, schistosomiasis still remains a major public health issue in sub Saharan 
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Africa where, instead of reduction, there are reports of increased spread in new geographic areas. 
Furthermore, there are also reports of resistance to praziquantel, the cornerstone of 
schistosomiasis control ,but because worm reproduction in human host is sexual and generation 
time is relatively long, resistance is likely to take many years to become an important clinical 
and public health issue [King 2000,]. 
Measures for control include chemotherapy using praziquantel, snail control 
(molluscicide), cercariae and miracidia control, provision of safe water supply, and health 
education by encouraging healthy behaviors such as use of latrines and change in defecation 
habits. To achieve optimal benefits from the disease control strategies, it is appropriate to 
recognize the seasonal factors that affect transmission of the parasitic and environmental 
heterogeneities of host population. [Kabatereine 2004] 
 
1.3.1 Human Chemotherapy 
Due to lack of resources, drug treatment can not cover every infected human host in the area. To 
achieve the best result of chemotherapy, one generally needs to identify the high-risk groups and 
concentrate on them. 
1.3.2 Age-based Treatment 
School-age children constitute a high-risk population and as children, they typically have the 
highest intensity of schistosomiasis infection of any age group.  Chronic infection negatively 
affects all aspects of children’s health, nutrition, cognitive development, learning, and 
  10 
educational access and achievement [World Bank 2003]. In general, children are easier to cover 
with mass drug treatment because they are readily available to be reached through schools which 
offer a sustained infrastructure with a skilled workforce that is in close contact with the 
community. Child-treatment reduces disease transmission; hence infection levels in community 
decline even for untreated children. The effect is greater because of the behavioral and biological 
differences between adults and children. By reducing transmission of schistosomiasis infections, 
deworming can improve the health and school participation of both treated and untreated 
children, both in treatment schools and in neighboring schools [Miguel and Kremer 2003].  
Not only school-age children are at risk but also preschool children are vulnerable to the 
developmental and behavioral deficits caused by iron deficiency anemia ,and according to 
Booker and Hotez [2004] worms are an important contributor to anemia in that age group. 
Women at reproductive age are particularly susceptible to iron deficiency anemia because of iron 
loss during menstruation and because of increased need during pregnancy [Savioli 1995]. The 
severe iron-deficiency anemia that can arise from schistosomiasis disease during pregnancy can 
have adverse results for the mother, the fetus, and the neonate. [Savioli 2000] 
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2.0  OBJECTIVE 
The objective of this thesis is to examine the country-level association between the estimated 
prevalence of schistosomiasis and indicators of socio-demographic status in Sub Saharan Africa. 
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3.0  METHODS 
3.1 DATA SOURCES  
An online World Health Organization (WHO) report was used to identify the population at risk 
of schistosomiasis and those infected in Sub Saharan African countries at mid -2008[WHO, 
2008]. The World Health Statistics report was also used to identify the total population of each 
individual country included in this thesis. [WHO, 2008]. From this same report, other useful 
country-level parameters were used: adult literacy, infant mortality rate, percentage of children 
under 15 years old, percentage of population living in rural area, percentage of population living 
under two dollars per day, number of physicians and nurses per ten thousand population . Also 
the percentage of population with no access to clean water by country was obtained from a 
UNICEF website [WHO/UNICEF 96]. 
 
 
 
  13 
3.2 DATA ANALYSIS 
Given the total population (TP) of each individual country and the number of persons infected 
(PI), prevalence of infection (PREV) was calculated by dividing the population infected (PI) by 
total population (TP) times 100. Countries were categorized as “high” prevalence if prevalence 
of infection was greater or equal to 30 percent and “low” prevalence if less than 30 percent. Then 
t-test was also used to assess the difference between mean levels of each variable in “high” and 
“low” prevalence countries. 
A Correlation coefficient matrix was used to determine correlations between all social -
demographic variables and outcome (Table 3).Scatter plots were also used to assess relationship 
between each risk factor and prevalence of infection (PREV). 
 Linear regression was used to identify measures independently associated with 
schistosomiasis prevalence and 3 risk factors were initially included (PR15, ADLIT, MD). 
Stepwise backward elimination method was used. 
All statistical analyses were performed using version 9.2 of SAS software (SAS Institute, 
Cary, NC, USA). 
 
  14 
4.0  METHODS 
4.1 POPULATION 
As presented on Table 1, the median percentage of young people (%Y15) in endemic sub-
Saharan African countries is 43 percent and young persons are at high risk for schistosomiasis. 
The median percentage of rural population (%Rul.) is 63 percent and this group is mostly poor 
without access to basic infrastructures such as clean water, in other words, it is at high risk for 
schistosomiasis and other diseases of poverty. A median of 77 percent of the population (%$2) 
lives in extreme poverty, on less than two dollars per day, in disease conditions, struggling for 
the most basic necessities. The median child mortality rate (CM5) is 126 per thousand. The 
median number of physicians (MD) is 1 per ten thousand and the median number of nurses 
(NUR) is 6 per ten thousand population. The median percentage of literate adults (ADLIT) is 65 
percent and the median percentage of those without clean water (NWAT) is 36 percent
  15 
Country Infected At Risk Tot.Pop. %Y15 %RI PREV%Rul.%$2 CM5 ADLITMD NUR NWAT
Angola 7,777,514 10,499,644 18,020,668 46 58 43 43 73 158 67 1 14 49
Benin 3,300,594 7,447,494 8,662,086 44 86 38 59 75 123 41 0 8 35
Botswana 190,552 476,379 1,904,991 35 25 10 40 49 40 83 4 27 4
Burkina Faso 4,563,995 12,170,652 15,208,586 46 80 30 84 81 191 29 1 5 28
Burundi 1,180,830 3,936,099 8,074,254 41 49 15 90 93 180 59 0 2 29
Cameroon 4,296,174 16,188,893 18,897,957 42 86 23 44 58 148 68 2 16 30
Central African 
Republic 442,429 3,760,650 4,423,452 41 85 10 62 82 172 49 1 4 34
Chad 4,816,218 8,759,279 11,067,437 46 79 44 73 83 209 26 0 3 52
Congo 1,316,922 2,693,032 3,615,152 42 74 36 40 74 125 87 2 10 29
Côte d'Ivoire 7,849,695 18,624,238 20,591,302 41 90 38 52 47 127 49 1 6 19
Democratic 
Republic of the 
Congo 18,275,470 50,468,820 64,205,366 47 79 28 67 80 161 67 1 5 54
Equatorial 
Guinea 10,394 103,939 659,197 42 16 2 61 206 87 3 5 57
Eritrea 361,521 2,655,791 4,996,204 43 53 7 79 70 1 6 40
Ethiopia 6,043,909 45,163,108 80,713,434 44 56 7 84 78 119 36 0 2 58
Gabon 613,706 675,077 1,448,159 35 47 42 16 20 91 86 3 50 13
Gambia 526,220 1,403,254 1,660,200 41 85 32 44 57 109 1 13 14
Ghana 17,364,943 22,459,043 23,350,927 40 96 74 52 54 115 65 2 9 20
Guinea 2,465,526 9,572,042 9,833,055 43 97 25 67 87 150 30 1 5 30
Guinea-Bissau 523,751 1,396,668 1,575,446 43 89 33 70 78 198 65 1 7 43
Kenya 8,864,989 30,839,766 38,534,087 43 80 23 81 40 121 74 1 12 43
Liberia 946,132 3,153,772 3,793,400 47 83 25 42 95 133 56 0 3 36
Madagascar 11,125,739 16,172,162 19,110,941 43 85 58 70 90 112 71 3 3 53
Malawi 6,123,589 11,430,699 14,278,404 46 80 43 83 90 111 72 0 6 24
Mali 3,814,824 10,172,864 12,711,140 45 80 30 69 77 196 23 1 6 40
Mauritania 877,520 2,562,917 3,200,288 40 80 27 60 44 119 56 1 6 40
Mozambique 15,214,927 17,450,040 21,780,614 43 80 70 69 90 168 44 0 3 58
Namibia 12,613 262,067 2,114,161 37 12 1 65 62 68 88 3 31 7
Niger 1,988,657 11,784,635 14,668,743 49 80 14 83 86 176 30 0 2 58
Nigeria 35,154,357 121,182,498 151,319,500 45 80 23 53 84 189 72 3 17 53
Rwanda 594,262 1,000,862 9,720,694 44 10 6 72 90 181 64.9 1 4 35
Sao Tome and 
Principe 6,161 29,571 160,954 41 18 4 42 99 88 5 19 14
Senegal 1,940,460 10,150,100 12,211,181 42 83 16 59 60 114 43 1 3 23
Sierra Leone 3,552,693 5,257,985 5,559,853 43 95 64 63 76 262 38 0 5 32
Somalia 1,612,081 4,478,002 8,953,890 44 50 18 63 142 0 2 71
South Africa 5,295,051 30,275,051 48,687,000 32 62 11 39 43 59 88 8 41 7
Sudan 7,165,105 31,556,010 41,347,723 40 76 17 62 109 60.9 3 9 36
Swaziland 293,443 918,606 1,167,834 39 79 25 76 63 91 80 2 63 40
Togo 1,698,852 5,409,938 6,458,605 43 84 26 60 69 100 53 0 4 41
Uganda 5,104,418 25,522,089 31,656,865 49 81 16 87 76 130 74 1 7 36
United Republic 
of Tanzania 21,348,317 33,171,138 42,483,923 44 78 50 75 97 116 72 0 4 45
Zambia 3,227,578 9,723,578 12,620,219 46 77 26 63 82 170 68 1 20 42
Zimbabwe 5,392,494 10,784,987 12,462,879 38 87 43 63 90 91 2 7 19
Median 3,264,086 9,647,810 11,639,309 43 80 25 63 77 126 65 1 6 36
Table 1: Country_ Level Socio-Demographic Measures                         
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5.0  RESULTS 
5.1.1 T-test Results of differences between “high” and “low” prevalence countries 
Analyses of differences between “high” and “low” prevalence countries compare mean values of 
each variable within “low” and “high” prevalence categories and the results of T-test are shown 
on Table 2. Mean number of physicians and mean adult literacy rates were significantly different 
(P=0.015 and 0.0112 respectively) in “high” and “low” prevalence countries. 
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Table 2:  Mean Values of Socio-Demographic Variables by Prevalence of Schistosomiasis 
Country-Level 
Variable 
Low Prevalence   
Countries (<30%) 
N=25 
High Prevalence countries 
(>=30%) 
N=17 
P-value 
%Y15 
 
42 43 0.75 
%Rul. 
 
64 60 0.50 
%$2 
 
71 73 0.64 
‰CM5 
 
130 147 0.24 
%ADLIT 
 
64 48 0.011 
 MD 
 
2 1 0.015 
 NUR 
 
13 9 0.23 
NWAT 
 
37(25) 34 0.53 
 
Variables:  %Y15: percentage of persons under 15 years old, %Rul. (percentage of rural population), 
%$2(percentage of those population living under $2 per day), ‰CM5 (child mortality rate per a thousand),% 
ADLIT(adult literacy rates),MD( number of physicians per ten thousand), NUR( number of nurses per ten 
thousand),NWAT( percentage of population without clean water). 
5.1.2 Correlation Coefficients and Relationship between Risk Factors and Prevalence of 
Infection 
Correlation coefficients were used to assess correlation between each risk factor and outcome 
and results are presented in Table 3. The relationship between risk factors and prevalence of 
infection was also assessed using scatter plots (Figures 2, 3). 
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Level of adult literacy rates (%ADLIT) is strongly correlated with prevalence of infection 
(PREV) (θ=-0.46) (Table 3 and  Figure 2).Number of physicians (MD) per ten thousand 
population and percentage of population under 15 years (%Y15) are also significantly correlated 
with prevalence of infection( Table 3 and Figure 3). 
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Table 3: Correlation Coefficients between Prevalence of Infection and Risk Factors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pearson Correlation Coefficients 
 
                                  Prob > |r| under H0: Rho=0 
 
                                     Number of Observations (n) 
 
             PREV      %Y15      %Rul     %$2     CM5         ADLIT        MD       NUR      NWAT 
 
  PREV    1.00000   0.30677   0.13213   0.13463   0.21438  -0.46078  -0.38458  -0.25509   0.15375 
   PREV              0.0482    0.4042    0.4337    0.1728    0.0032    0.0119    0.1030    0.3310 
              42        42        42        36        42        39        42        42        42 
 
 
 %Y15     0.30677   1.00000   0.51444   0.68971   0.57748  -0.50108  -0.68947  -0.61531   0.65329 
 %Y15      0.0482              0.0005    <.0001    <.0001    0.0012    <.0001    <.0001    <.0001 
              42        42        42        36        42        39        42        42        42 
 
 
 %Rul    0.13213   0.51444   1.00000   0.56279   0.29731  -0.39479  -0.51267  -0.42343   0.45092 
 %Rul     0.4042    0.0005              0.0004    0.0559    0.0129    0.0005    0.0052    0.0027 
              42        42        42        36        42        39        42        42        42 
 
 
  %$2    0.13463   0.68971   0.56279   1.00000   0.52920  -0.37096  -0.51287  -0.57275   0.56242 
   %$2    0.4337    <.0001    0.0004              0.0009    0.0282    0.0014    0.0003    0.0004 
              36        36        36        36        36        35        36        36        36 
 
 
 CM5     0.21438   0.57748   0.29731   0.52920   1.00000  -0.53815  -0.45458  -0.45870   0.50860 
  CM5     0.1728    <.0001    0.0559    0.0009              0.0004    0.0025    0.0022    0.0006 
              42        42        42        36        42        39        42        42        42 
 
 
 ADLIT  -0.46078  -0.50108  -0.39479  -0.37096  -0.53815   1.00000   0.62257   0.53250  -0.37335 
  ADLIT   0.0032    0.0012    0.0129    0.0282    0.0004              <.0001    0.0005    0.0192 
              39        39        39        35        39        39        39        39        39                        
           
 
 MD      -0.38458  -0.68947  -0.51267  -0.51287  -0.45458   0.62257   1.00000   0.59440  -0.49612 
 MD        0.0119    <.0001    0.0005    0.0014    0.0025    <.0001              <.0001    0.0008 
              42        42        42        36        42        39        42        42        42 
 
 
 NUR     -0.25509  -0.61531  -0.42343  -0.57275  -0.45870   0.53250   0.59440   1.00000  -0.42998 
 NUR       0.1030    <.0001    0.0052    0.0003    0.0022    0.0005    <.0001              0.0045 
              42        42        42        36        42        39        42        42        42 
 
 
 NWAT     0.15375   0.65329   0.45092   0.56242   0.50860  -0.37335  -0.49612  -0.42998   1.00000 
 NWAT   0.3310    <.0001   0.0027   0.0004    0.0006   0.0192   0.0008   0.0045 
              42        42        42        36        42        39        42        42        42 
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5.1.3 Scatter Plots 
Adult literacy rate is indirectly related to prevalence of infection (Fig.3) 
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Figure 3:  Adult Literacy Rates and Risk of Infection 
Low number of physicians is assocated with higher prevelence of infection( Fig.4) 
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Figure 4:  Risk of Infection and Number of Physicians              
5.1.4 Linear Regression for Factors Associated with Infection 
In order to determine the factors that are associated with infection, the data were analyzed using 
linear regression. 
 Initially two factors (ADLIT and MD) were included based on the t-test results and by 
stepwise backward elimination; adult literacy rates (ADLIT) remained significantly associated 
with prevalence of infection (P< 0.0032). Table 4 presents the results of linear regression 
analysis at final stage with adult literacy rates as independent variable: (OR=0.576;95% CI 
0.404, 0.820).An Odds ratio less than 1 suggests that as adult literacy increases, prevalence of 
infection decreases. In other words, literacy is a protective factor. 
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Table 4: Linear Association of Adult Literacy Rate and Prevalence of Schistosomiasis in Sub-Saharan 
African Countries 
                                   
        Variable   Label     DF                      Odds ratio                  95% Confidence Interval 
 
        ADLIT     ADLIT      1                               0.576                      0.404     0.820 
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6.0  DISCUSSION 
Schistosomiasis is a multifactorial disease, prevalent in impoverished and often vulnerable 
people living in conditions that favor transmission, without proper access to health care or 
prevention measures. The occurrence is particularly linked to agricultural and water development 
schemes which paradoxically, by improving water access also increase the habitat of snail, thus 
extending the areas where schistosomiasis is found. 
In this thesis, the following risk factors that may increase likelihood of exposure and 
transmission were used: young population under 15 years old because of their interaction with 
unsafe water and lack of immunity against schistosomiasis, rural population without adequate 
health infrastructure, people living in extreme poverty, child mortality (under 5 years), adult 
literacy rates, number of physicians, number of nurses, and people with no access to clean water. 
 Adult literacy rate (ADLIT) was significantly associated with prevalence of infection 
using country –level data. 
Adult literacy may decreases risk of infection because of other implications such as following 
instructions to protect against potentially contaminated water. 
            The data used have some limitations. Most developing countries do not have resources to 
collect data on most of the neglected diseases .They usually put priority on diseases such as HIV-
AIDS, malaria, and TB. Some countries in sub-Saharan Africa are involved in continuous wars 
and violence (Somalia, Republic Democratic of Congo, and Sudan for example) and it is 
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impossible to conduct any survey. It was also reported that some data were just the result of 
generalization from one country to another [Van der Werf 2003]. 
In this thesis, the focus was on prevalence of infection which gives notion to potential 
morbidity but it’s not known when those who are infected will be sick because it takes long time 
depending on other conditions: intensity of infection, length of infection, co-infection, nutrition, 
immunity, age, gender, climate, altitude, and other factors. Approximately 50-60 % of those 
infected develop symptoms but people with lighter infection have fewer or no symptoms and 
severe disease may follow after many years of silent or mildly symptomatic period [WHO 1993].   
In addition, national prevalence may hide the real picture of disease in a given 
population. As a disease of conditions on ground, schistosomiasis should be treated mostly 
locally (living near rivers, dams, lakes, irrigation ditches) because that is the area which is 
unevenly impacted by the disease. For example, in Rwanda, the national prevalence is about 6% 
but it is above 60 % in some areas such as northern region close to the lakes Bulera and Ruhondo 
[Ruberanziza 2007] 
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7.0  CONCLUSION 
Schistosomiasis like other neglected diseases is a disease of poverty. It is mostly prevalent in 
Sub- Saharan Africa where not only it overlaps with other low priority (politically) diseases but 
also high priority diseases such as HIV, malaria, and TB. Schistosomiasis has low mortality but 
high morbidity rates and because of prioritization, the high mortality diseases are treated first. 
Thus an integration of schistosomiasis control programs with efforts to curb these high priority 
diseases has been repeatedly advocated [Molyneaux, 2004; Hotez et al.2006]. It is helpful, not 
only to recognize the countries with high prevalence in schistosomiasis but also to identify the 
risk factors.   Low literacy increases chances of infection and we believe that increasing literacy 
rates may decrease infection by schistosomiasis. Information on such disease should be provided 
to local population by formal and informal education in schools, multimedia (TV, radio, 
magazine, booklets) and meetings within communities. Education on neglected tropical diseases 
(NTD) does not only consist in increasing literacy but also increasing hygienic behaviors such as 
using toilets and avoiding contaminated water. 
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